Oruka Therapeutics (ORKA) EPS (Basic) (2010 - 2024)
Oruka Therapeutics' (ORKA) quarterly EPS (Basic) came in at -$14.95 in Q2 2024, down 1077.54% year-on-year from $1.53 in Q3 2023, and down 157.82% quarter-over-quarter from -$5.8 in Q1 2024.
Oruka Therapeutics (ORKA) EPS (Basic) (2010 - 2024) Analysis & Trends
Oruka Therapeutics' EPS (Basic) history runs 15 years deep, the most recent figure standing at -$14.95 for Q2 2024.
- On a quarterly basis, EPS (Basic) fell 1077.54% year-over-year to -$14.95 in Q2 2024; TTM through Mar 2025 was -$0.43, a 95.41% increase from a year earlier, with the FY2023 full-year figure at -$50.67, up 5.36% from the prior year.
- EPS (Basic) eased to -$14.95 in Q2 2024 per ORKA's latest filing, from -$5.8 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.93 in Q4 2023 and bottomed at -$14.95 in Q2 2024.
- The 5-year median for EPS (Basic) is -$3.94 (2020), against an average of -$4.84.
- Across the five-year window, EPS (Basic) surged 80.04% in 2022 and sank 1077.54% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$13.36 in 2020, then surged by 63.33% to -$4.9 in 2021, then jumped by 80.04% to -$0.98 in 2022, then grew by 5.06% to -$0.93 in 2023, then plunged by 1511.17% to -$14.95 in 2024.
- Per Business Quant, the three latest ORKA EPS (Basic) figures stand at -$14.95 (Q2 2024), -$5.8 (Q1 2024), and -$0.93 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -14.95 |
| Mar 31, 2024 | -5.80 |
| Dec 31, 2023 | -0.93 |
| Sep 30, 2023 | -1.47 |
| Jun 30, 2023 | -1.27 |
| Mar 31, 2023 | -1.15 |
| Dec 31, 2022 | -0.98 |
| Sep 30, 2022 | -1.99 |
| Jun 30, 2022 | -3.04 |
| Mar 31, 2022 | -2.75 |
| Dec 31, 2021 | -4.90 |
| Sep 30, 2021 | -3.92 |
| Jun 30, 2021 | -4.03 |
| Mar 31, 2021 | -3.99 |
| Dec 31, 2020 | -13.36 |
| Sep 30, 2020 | -3.95 |
| Jun 30, 2020 | -8.71 |
| Mar 31, 2020 | -9.94 |
| Dec 31, 2019 | -11.14 |
| Sep 30, 2019 | -9.12 |